Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hahn

Showing results (1171-1180 of 1,198) with videos related to

Pageof 120
Sort By:
European Urology|December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on OutcomesMatthew D Galsky, Huan Wang, Noah M Hahn, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2013
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summaryPaul E Wallner, Mitchell S Anscher, Christopher A Barker, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Medrxiv : the Preprint Server for Health Sciences|May 13, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2026
Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trialZiao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits, et al.
Nature Communications|October 20, 2021
Regulation of local GTP availability controls RAC1 activity and cell invasionAnna Bianchi-Smiraglia, David W Wolff, Daniel J Marston, et al.
Nature|March 11, 2015
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerChristina Twyman-Saint Victor, Andrew J Rech, Amit Maity, et al.
The American Journal of Psychiatry|July 15, 2020
Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled StudyLaura E Dichtel, Linda L Carpenter, Maren Nyer, et al.
Nature Microbiology|July 29, 2024
SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacityMario A Peña-Hernández, Mia Madel Alfajaro, Renata B Filler, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Survey of white-footed mice in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronavirusesRebecca Earnest, Anne M Hahn, Nicole M Feriancek, et al.
Pageof 120

Showing results (1171-1180 of 1,198) with videos related to

Sort By:
Pageof 120
European Urology|December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on OutcomesMatthew D Galsky, Huan Wang, Noah M Hahn, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2013
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summaryPaul E Wallner, Mitchell S Anscher, Christopher A Barker, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Medrxiv : the Preprint Server for Health Sciences|May 13, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2026
Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trialZiao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits, et al.
Nature Communications|October 20, 2021
Regulation of local GTP availability controls RAC1 activity and cell invasionAnna Bianchi-Smiraglia, David W Wolff, Daniel J Marston, et al.
Nature|March 11, 2015
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerChristina Twyman-Saint Victor, Andrew J Rech, Amit Maity, et al.
The American Journal of Psychiatry|July 15, 2020
Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled StudyLaura E Dichtel, Linda L Carpenter, Maren Nyer, et al.
Nature Microbiology|July 29, 2024
SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacityMario A Peña-Hernández, Mia Madel Alfajaro, Renata B Filler, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Survey of white-footed mice in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronavirusesRebecca Earnest, Anne M Hahn, Nicole M Feriancek, et al.
Pageof 120